Trial Profile
Phase III, open-label, multi-centre study to assess the pharmacodynamic (PD), pharmacokinetic (PK) and safety of Zoreline 3.6 mg goserelin subcutaneous implant (Novalon) in women with confirmed endometriosis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Endometriosis
- Focus Pharmacodynamics
- Sponsors Novalon
- 10 Feb 2017 New trial record
- 31 Mar 2016 According to Mithra Pharmaceuticals media release, this study is expected to begin in summer 2016.